Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.

PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 13, 2012

Primary Completion Date

January 30, 2012

Study Completion Date

January 30, 2012

Conditions
Hypercholesterolaemia
Interventions
DRUG

10mg Ezetimibe

1 tablet taken by mouth

DRUG

10 mg Ezetimibe - wash out period

1 tablet taken by mouth received after wash out period

Trial Locations (1)

560100

GSK Investigational Site, Electronics City, Bengalore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY